Robert Foster, MD
Interventional Cardiology · Birmingham, ALNPI 1720163140
Payments from drug & device makers
Across 296 payments — averaging $1867.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Veryan Medical Incorporated$456K
- Medtronic$67K
- Endologix LLC$23K
- Philips North America LLC$2K
- Amgen$1K
- Silk Road Medical, Inc.$999
- plus $2K from 23 others
Across 1 payment — averaging $67,050 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Veryan Medical Incorporated$67K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Veryan Medical Incorporated | 43 | $455,628 |
| Medtronic(2 entities) | 97 | $67,257 |
| Endologix LLC | 34 | $23,318 |
| Philips North America LLC | 4 | $2,220 |
| Amgen | 6 | $1,254 |
| Silk Road Medical, Inc. | 9 | $999 |
| Novartis | 32 | $423 |
| Boston Scientific | 13 | $335 |
| Biocompatibles, Inc. | 9 | $152 |
| Johnson & Johnson | 10 | $152 |
| Pfizer | 10 | $148 |
| E.r. Squibb & Sons, L.L.C. | 1 | $122 |
| Asahi Intecc USA, Inc. | 1 | $94 |
| Angiodynamics, Inc. | 2 | $84 |
| Astellas Pharma US Inc | 4 | $73 |
| Merck | 3 | $69 |
| Abbott | 2 | $42 |
| Amarin Pharma, Inc. | 3 | $38 |
| Inari Medical, Inc. | 1 | $37 |
| Sanofi-aventis U.S. LLC | 2 | $29 |
| Siemens Medical Solutions USA, Inc. | 1 | $29 |
| Boehringer Ingelheim | 2 | $25 |
| Genentech USA, Inc. | 1 | $21 |
| Actelion Pharmaceuticals US, Inc. | 1 | $18 |
| Hikma Pharmaceuticals USA | 1 | $17 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $16 |
| Avanos Medical | 1 | $16 |
| Dompe US, Inc. | 1 | $16 |
| Z-medica, LLC | 1 | $12 |
How this compares
$552,649 in reported general payments places this provider in the 95th percentile of 109 interventional cardiology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other interventional cardiology in Birmingham
- Brigitta BrottBirmingham$376K
- Gary RoubinBirmingham$196K
- Massoud LeesarBirmingham$160K
- David SchultzBirmingham$95K
- Joshua CockrellBirmingham$93K
- Hasan GuvenBirmingham$86K
- Abdullah MahmoodBirmingham$61K
- Ali EbrahimiBirmingham$55K
- Jacob TownsendBirmingham$52K
- Kamran AliBirmingham$47K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.